A detailed history of D. E. Shaw & Co., Inc. transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 3,371,849 shares of ACRS stock, worth $9.74 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,371,849
Holding current value
$9.74 Million
% of portfolio
0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.12 - $1.4 $57,840 - $72,300
51,643 Added 1.56%
3,371,849 $3.81 Million
Q2 2024

Aug 14, 2024

BUY
$1.01 - $1.36 $37,596 - $50,624
37,224 Added 1.13%
3,320,206 $3.65 Million
Q1 2024

May 15, 2024

BUY
$0.92 - $1.44 $1.24 Million - $1.94 Million
1,343,972 Added 69.31%
3,282,982 $4.07 Million
Q4 2023

Feb 14, 2024

BUY
$0.64 - $6.49 $1.2 Million - $12.2 Million
1,873,000 Added 2837.45%
1,939,010 $2.04 Million
Q3 2023

Nov 14, 2023

BUY
$6.56 - $10.95 $243,290 - $406,102
37,087 Added 128.23%
66,010 $452,000
Q2 2023

Aug 14, 2023

BUY
$7.89 - $10.64 $228,202 - $307,740
28,923 New
28,923 $299,000
Q1 2022

May 16, 2022

SELL
$9.74 - $17.92 $222,695 - $409,722
-22,864 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$12.27 - $18.49 $500,100 - $753,615
-40,758 Reduced 64.06%
22,864 $332,000
Q3 2021

Nov 15, 2021

SELL
$13.38 - $18.8 $2.75 Million - $3.87 Million
-205,633 Reduced 76.37%
63,622 $1.15 Million
Q2 2021

Aug 16, 2021

BUY
$17.08 - $29.6 $4.6 Million - $7.97 Million
269,255 New
269,255 $4.73 Million
Q1 2020

May 15, 2020

SELL
$0.75 - $2.18 $52,326 - $152,096
-69,769 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$1.02 - $1.97 $644,329 - $1.24 Million
-631,696 Reduced 90.05%
69,769 $132,000
Q3 2019

Nov 14, 2019

BUY
$0.79 - $2.47 $25,442 - $79,548
32,206 Added 4.81%
701,465 $758,000
Q2 2019

Aug 14, 2019

SELL
$2.13 - $7.06 $2.52 Million - $8.36 Million
-1,183,610 Reduced 63.88%
669,259 $1.47 Million
Q1 2019

May 15, 2019

SELL
$5.63 - $7.84 $2.4 Million - $3.34 Million
-425,495 Reduced 18.68%
1,852,869 $11.1 Million
Q4 2018

Feb 14, 2019

BUY
$6.3 - $15.4 $5.99 Million - $14.6 Million
950,781 Added 71.62%
2,278,364 $16.8 Million
Q3 2018

Nov 14, 2018

BUY
$14.38 - $20.89 $843,645 - $1.23 Million
58,668 Added 4.62%
1,327,583 $19.3 Million
Q2 2018

Aug 14, 2018

BUY
$16.46 - $20.33 $504,153 - $622,687
30,629 Added 2.47%
1,268,915 $25.3 Million
Q1 2018

May 15, 2018

BUY
$17.08 - $25.64 $3.67 Million - $5.52 Million
215,158 Added 21.03%
1,238,286 $21.7 Million
Q4 2017

Feb 14, 2018

BUY
$21.47 - $27.8 $21.7 Million - $28.1 Million
1,010,970 Added 8315.27%
1,023,128 $25.2 Million
Q3 2017

Nov 14, 2017

BUY
$23.02 - $28.8 $279,877 - $350,150
12,158
12,158 $314,000

Others Institutions Holding ACRS

About Aclaris Therapeutics, Inc.


  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $193M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.